Today: 7 February 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Shinhan Financial Group Co., Ltd. Stock (055550.KS / NYSE: SHG) Rises on Dec. 24, 2025: What Today’s News, Dividend Signals, and Analyst Forecasts Say

Shinhan Financial Group Co., Ltd. Stock (055550.KS / NYSE: SHG) Rises on Dec. 24, 2025: What Today’s News, Dividend Signals, and Analyst Forecasts Say

SEOUL / NEW YORK — December 24, 2025 — Shinhan Financial Group Co., Ltd. stock is ending the year with a familiar mix of catalysts: solid earnings power, steady capital returns, and headline risk from its credit-card unit. On Wednesday, the Korea-listed shares (KRX: 055550) finished higher even as the broader market slipped, while the U.S.-listed ADR (NYSE: SHG) traded firmly in a holiday-shortened week. Investing.com 한국어+2Korea Joongang Daily+2 Below is a full roundup of the current news, forecasts, and market analysis relevant as of Dec. 24, 2025, and what they could mean for Shinhan Financial Group stock into early
24 December 2025
·····
Advance Auto Parts Stock (NYSE: AAP) on Dec. 24, 2025: Latest News, Turnaround Forecasts, and Analyst Outlook

Advance Auto Parts Stock (NYSE: AAP) on Dec. 24, 2025: Latest News, Turnaround Forecasts, and Analyst Outlook

Dec. 24, 2025 — Advance Auto Parts, Inc. (NYSE: AAP) is back in focus heading into the holiday period after a volatile December for auto-parts retailers. Shares traded around $40–$41 on Dec. 24, bouncing from recent weakness as investors weigh the company’s turnaround execution, sector-wide pricing concerns, and a string of Wall Street notes. Even after today’s rebound, AAP is still moving inside a wide 52-week range of roughly $28.89 to $70.00, a reminder that the market remains deeply split on whether Advance Auto Parts is in a durable recovery—or just enjoying temporary relief rallies. MarketWatch+1 AAP stock today: where
24 December 2025
····
Micron Technology (MU) Stock Hits Fresh Records on Dec. 24, 2025: AI Memory Crunch, Blowout Guidance, and Wall Street’s Latest Forecasts

Micron Technology (MU) Stock Hits Fresh Records on Dec. 24, 2025: AI Memory Crunch, Blowout Guidance, and Wall Street’s Latest Forecasts

Micron Technology, Inc. (NASDAQ: MU) is closing out Christmas Eve trading in full “Santa rally” fashion. In the holiday-shortened U.S. session on December 24, 2025, Micron climbed to a record high and helped lift broader market sentiment as investors continued to reprice the company around one big theme: AI data centers are turning memory into the new choke point. Reuters By mid-day, MU was trading around the mid-$280s after pushing up near $289 intraday, extending the post-earnings surge that began last week. Benzinga+1 What changed isn’t that Micron “discovered AI” overnight—it’s that the company’s latest results and forward guidance arrived
24 December 2025
·····
POSCO Holdings Inc Stock (005490, PKX): LFP Cathode JV, US Expansion, and Fresh 2026 Analyst Forecasts on Dec. 24, 2025

POSCO Holdings Inc Stock (005490, PKX): LFP Cathode JV, US Expansion, and Fresh 2026 Analyst Forecasts on Dec. 24, 2025

December 24, 2025 — POSCO Holdings Inc. is ending the year with a familiar identity crisis—in a good way for investors. It’s still a steel heavyweight, but more and more of the market narrative is about battery materials, lithium resource security, and “green steel” pathways that could reshape earnings power over the next few years. On Dec. 24, 2025, POSCO Holdings’ Korea-listed shares closed at KRW 314,000 (+3.29%) as attention returned to the group’s “second engine”: energy and battery materials. Investing.com What changed today isn’t a single line item in a quarterly report. It’s momentum—driven by a concrete project announcement
24 December 2025
·····
Zeta Global (ZETA) Stock Surges on Dec. 24, 2025: Holiday Trading Spike, Analyst Targets, and the Marigold Growth Story

Zeta Global (ZETA) Stock Surges on Dec. 24, 2025: Holiday Trading Spike, Analyst Targets, and the Marigold Growth Story

Zeta Global Holdings Corp. (NYSE: ZETA) shares climbed sharply in the Christmas Eve session, extending a late-December rebound as investors continued to price in the company’s expanded 2025–2026 outlook following its Marigold enterprise acquisition and a run of “beat-and-raise” execution. As of roughly midday New York time on December 24, 2025, ZETA traded near $19.15, up about 4.36% on the day after opening at $19.01, with an intraday range of roughly $18.36 to $19.39 on about 4.0 million shares of volume. The move is landing in a shortened U.S. trading session—a detail that matters more than most people think. Both
24 December 2025
···
Almonty Industries Inc. Stock (ALM) News and Forecasts on Dec. 24, 2025: Sangdong Mining Milestone, $129M Financing, and Analyst Targets for 2026

Almonty Industries Inc. Stock (ALM) News and Forecasts on Dec. 24, 2025: Sangdong Mining Milestone, $129M Financing, and Analyst Targets for 2026

December 24, 2025 — Almonty Industries Inc. has become one of the more closely watched “critical minerals” names on U.S. markets as investors try to price a rare combination: a Western-aligned tungsten supply story, a major mine transitioning from development into operations, and a fresh round of growth capital that management says fully funds its current expansion plans. On Dec. 24, 2025, Almonty’s Nasdaq-listed shares (NASDAQ: ALM) traded around the mid-$9 range during the session. MarketBeat Below is a full roundup of the current stock-moving news, forecasts, and market analysis available as of 24.12.2025, including the latest company releases, capital-markets
24 December 2025
·····
Zai Lab Limited (ZLAB) Stock Surges After China Approves COBENFY for Schizophrenia: News, Forecasts, and Analyst Outlook on Dec. 24, 2025

Zai Lab Limited (ZLAB) Stock Surges After China Approves COBENFY for Schizophrenia: News, Forecasts, and Analyst Outlook on Dec. 24, 2025

December 24, 2025 — Zai Lab Limited (NASDAQ: ZLAB, HKEX: 9688) is back in the spotlight after a major regulatory catalyst in China helped lift sentiment around the biopharma name. The company announced that China’s National Medical Products Administration (NMPA) approved COBENFY (xanomeline and trospium chloride) for schizophrenia in adults—a decision that quickly rippled into trading on both its U.S. ADR and Hong Kong listings. Business Wire+1 As of Dec. 24, 2025, Zai Lab’s U.S.-listed ADR was trading around $18.54 intraday (open $18.39, high $19.01), as risk-on buyers reacted to the approval headline and the company’s broader “pipeline-to-commercial” story. MarketBeat
24 December 2025
····
Wave Life Sciences (WVE) Stock: December 24, 2025 News Roundup, Analyst Forecasts, and What Investors Are Watching Next

Wave Life Sciences (WVE) Stock: December 24, 2025 News Roundup, Analyst Forecasts, and What Investors Are Watching Next

Wave Life Sciences Ltd. (NASDAQ: WVE) is ending 2025 as one of biotech’s most watched “story stocks”—the kind that can go from sleepy to screaming in a single premarket headline, then spend weeks digesting what just happened. On December 24, 2025, Wave shares traded in the high teens (around ~$18), still hovering near the re-rated levels that followed its early obesity readout and a sizable capital raise earlier this month. Multiple market data sources showed WVE around $18.1–$18.5 intraday, with the day’s range roughly $17.49 to ~$18.5. StockAnalysis+2Investing.com Australia+2 Below is a consolidated, publication-ready look at the most relevant WVE
24 December 2025
····
Travere Therapeutics (TVTX) Stock Jumps on Dec. 24, 2025: 52-Week High, FDA Catalyst Ahead, and Analyst Price Targets

Travere Therapeutics (TVTX) Stock Jumps on Dec. 24, 2025: 52-Week High, FDA Catalyst Ahead, and Analyst Price Targets

Travere Therapeutics, Inc. (NASDAQ: TVTX) is ending 2025 with a bang. In the holiday-shortened U.S. trading session on Wednesday, December 24, 2025, TVTX surged sharply—pushing to fresh highs as investors recalibrated around two big themes: accelerating commercial execution for FILSPARI (sparsentan) and a looming FDA decision that could expand the drug into a second major kidney disease indication. StockAnalysis+2New York Stock Exchange+2 TVTX stock action on Dec. 24, 2025: a thin-session breakout with big numbers In early trading on Dec. 24, TVTX was up roughly 15% and changing hands around the low $40 range—an outsized move for a single session,
24 December 2025
·····
UiPath (PATH) Stock Jumps on S&P MidCap 400 Addition: Price Move, Analyst Targets, and What to Watch Next

UiPath (PATH) Stock Jumps on S&P MidCap 400 Addition: Price Move, Analyst Targets, and What to Watch Next

NEW YORK — December 24, 2025 — UiPath Inc. (NYSE: PATH) is having a headline-grabbing Christmas Eve session, with shares climbing sharply after S&P Dow Jones Indices selected UiPath for inclusion in the S&P MidCap 400. In late-morning U.S. trading, PATH hovered around $17.25, up roughly 8% on the day, after opening higher and trading between roughly $16.70 and $17.36. StockAnalysis The move is landing during a holiday-shortened session (U.S. equities close early on Christmas Eve), which can magnify price swings as liquidity thins out. Investopedia UiPath stock price today: what the market is reacting to The catalyst isn’t a
24 December 2025
···
Polestar Stock (PSNY) Surges on Fresh Funding: Latest News, Analyst Forecasts, and What Investors Are Watching (Dec. 24, 2025)

Polestar Stock (PSNY) Surges on Fresh Funding: Latest News, Analyst Forecasts, and What Investors Are Watching (Dec. 24, 2025)

Polestar Automotive Holding UK PLC (Nasdaq: PSNY) is back in the market spotlight on December 24, 2025, with the stock rallying sharply as investors digest a string of balance-sheet moves designed to extend liquidity, reduce leverage, and keep the company’s Nasdaq listing in good standing. Business Wire+2Reuters+2 The quick version: PSNY traded around $17.09, up roughly 13% on the day, after Polestar announced $300 million in new equity, a plan for ~$300 million of debt to convert into equity, and a Geely-backed term loan facility of up to $600 million. Those are big numbers for a company that has been
24 December 2025
·····
Edgewise Therapeutics Stock (EWTX) Jumps on EDG-7500 CIRRUS-HCM Update: Dec. 24, 2025 News, Analyst Forecasts, and Key Catalysts

Edgewise Therapeutics Stock (EWTX) Jumps on EDG-7500 CIRRUS-HCM Update: Dec. 24, 2025 News, Analyst Forecasts, and Key Catalysts

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) stock surged in intraday trading on Wednesday, December 24, 2025, after the company released a fresh update on EDG-7500, its investigational therapy for hypertrophic cardiomyopathy (HCM). By late morning, shares were trading around $26.37—up roughly 21% versus the prior close—after swinging between about $21.30 and $27.05 on the day, with volume above 2.2 million shares. The move follows a company announcement that it has completed Parts B and C of its Phase 2 CIRRUS-HCM trial and reported favorable interim safety observations from Part D—an update that several market outlets characterized as a meaningful de-risking moment
24 December 2025
····
1 … 540 541 542 543 544 … 880

Stock Market Today

Carvana stock jumps 5% to $403.67 — here’s what CVNA traders are watching next

Carvana stock jumps 5% to $403.67 — here’s what CVNA traders are watching next

7 February 2026
Carvana shares rose 5.21% Friday to $403.67, rebounding after recent volatility sparked by a short-seller report from Gotham City Research. The company denied allegations of overstated earnings and undisclosed ties to DriveTime. Carvana will report Q4 and full-year 2025 results after markets close on Feb. 18. The January U.S. CPI report is scheduled for Feb. 13.
Confluent stock hugs IBM’s $31 bid — here’s what investors watch next week

Confluent stock hugs IBM’s $31 bid — here’s what investors watch next week

7 February 2026
Confluent shares closed at $30.57 Friday, 43 cents below IBM’s $31-per-share cash offer, ahead of key events next week. The company will report earnings Feb. 11 without a call or outlook, and shareholders vote on the merger Feb. 12. Confluent disclosed 17 demand letters and two lawsuits over proxy disclosures but denies wrongdoing. The IBM deal values Confluent at $11 billion.
Go toTop